Response to I. Batinic-Haberle et al

Antioxid Redox Signal. 2016 Mar 20;24(9):525-6. doi: 10.1089/ars.2016.29029.hhs.

Harald H H W Schmidt¹, Roland Stocker^{2

3}, Gøran Paulsen⁴, Pietro Ghezzi⁵, Dennis Riley⁶, Andreas Daiber⁷, Antonio Cuadrado^{8

9

10

11}

¹ 1 Department of Pharmacology and Personalised Medicine, Cardiovascular Research Institute Maastricht, Faculty of Health, Medicine and Life Sciences, Maastricht University , Maastricht, the Netherlands .
² 2 Victor Chang Cardiac Research Institute , Sydney, Australia .
³ 3 University of New South Wales , Sydney, Australia .
⁴ 4 Norwegian School of Sport Sciences , Oslo, Norway .
⁵ 5 Brighton & Sussex Medical School , Brighton, United Kingdom .
⁶ 6 Galera Therapeutics, Inc. , Malvern, Pennsylvania.
⁷ 7 Labor für Molekulare Kardiologie, Zentrum für Kardiologie, Universitätsmedizin der Johannes Gutenberg-Universität , Mainz, Germany .
⁸ 8 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) , ISCIII, Madrid, Spain .
⁹ 9 Instituto de Investigaciones Biomédicas "Alberto Sols" UAM-CSIC , Madrid, Spain .
¹⁰ 10 Instituto de Investigación Sanitaria La Paz (IdiPaz) , Madrid, Spain .
¹¹ 11 Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid , Madrid, Spain .

No abstract available

Publication types